Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 14, 2005; 11(18): 2733-2738
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2733
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2733
Table 1 Islet allograft survival and animal survival in recipients treated with CsA and MMF.
| Variable | Group A Controls n = 12 | Group B CsA n = 11 | Group C MMF n = 11 | P x2 |
| 3rd-d graft survival (%) | 3 (25) | 9 (82) | 9 (82) | <0.01 |
| Graft survival in days after | 0 (1.2) | 10 (4.9) | 12 (5.1) | Kruskal Wallis |
| Tx (median SD) | <0.01 | |||
| Animal survival in days | 8.1 (3.7) | 12 (0.0) | 12 (0.0) | Kruskal Wallis |
| after Tx (median SD) | <0.01 |
-
Citation: Fotiadis C, Xekouki P, Papalois AE, Antonakis PT, Sfiniadakis I, Flogeras D, Karampela E, Zografos G. Effects of mycophenolate mofetil
vs cyclosporine administration on graft survival and function after islet allotransplantation in diabetic rats. World J Gastroenterol 2005; 11(18): 2733-2738 - URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2733.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i18.2733